biotech · Neonatal Infections · Locally Advanced / Metastatic Solid Tumors · CBIO
CRESCENT BIOPHARMA
CRESCENT BIOPHARMA, INC.
CRESCENT BIOPHARMA is a biotech organization headquartered in Waltham, USA. It trades on NYSE under ticker CBIO. Primary therapeutic focus areas include Neonatal Infections, Locally Advanced / Metastatic Solid Tumors, Ac
Waltham, USA HQ
57 Employees
Public company Type
CBIO · NYSE Ticker
Company details
- Status
- Public
- HQ
- Waltham, USA
- Employees
- 57
- Programs
- 3
- Drugs
- 5
- Patents
- 2
Chlorhexidine
Approved · small molecule · Neonatal Infections
Chlorhexidine for Neonatal Infections is a Approved program (small_molecule) at CRESCENT BIOPHARMA, INC. with 1 ClinicalTrials.gov record(s).
Internal code 3106-Ped-ERC-14
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- CRESCENT BIOPHARMA, INC.
- Phase
- Approved
- Modality
- small_molecule
- Indication
- Neonatal Infections
- Status
- completed
- Trials
- 1